How Pharmaceutical Manufacturers
Qualify for Section 41
Get rewarded for solving everyday problems of your contract pharmaceutical manufacturing business
Have you been performing these day-to-day activities?
- Manufacturing process stability testing;
- Safety standard evaluations for manufacturing process;
- Packaging alternatives review and testing;
- Bioequivalence testing;
- Characterization of reference drugs;
- Drug substance process research, development and scaling;
- Formulation development; and
- Comprehensive regulatory compliance reviews.
NEED HELP WITH R&D CREDIT?
Fill out the form to receive more information
R&D | Service Page / Contact-Us
Contact us to receive more information about the R&D Tax Credit.
Real Results from Pharmaceutical Manufacturers
PHARMACEUTICAL MANUFACTURER
Annual Revenue: $5 MM
Received:
$712,500 credits
MANUFACTURER OF GENERIC PHARMACEUTICALS
Annual Revenue: $140 MM
Received:
$870,500 credits
PHARMACEUTICAL MANUFACTURER
Annual Revenue: $20 MM
Received:
$1.4 MM credits
Real Results from Pharmaceutical Manufacturers
The pharmaceutical manufacturing industry has been under heavy pressure to drive innovation. But the industry has had to adapt to challenges. These include:
- Supply Chain Disruption
These are caused by:- Raw material shortage
- Unprecedented changes in demand pattern
- Inability to plan lead times
- Labor shortage
- Delayed Regulatory Oversight of Medicine Production
- Pandemic-related travel restrictions due to delayed inspection of drug manufacturing plants in China and India
- High Investment, Low Success
Between 2011-2020, only 7.9% of projects received the likelihood of approval (LOA) in phase 1. The US pharma industry on the other hand spent $90 billion in 2020 on R&D.
It is incentives like the R&D Tax Credit that are designed to mitigate these challenges and help pharmaceutical manufacturers stay ahead of the curve, while uncovering additional dollars for innovation and business growth.
Importance of the
R&D Tax Credit
The Research and Development (“R&D”) tax credit has continuously evolved since its inception in the 1980s. Introduced to increase the competitiveness of U.S.-based businesses and promote innovative activities, it has now grown into one of the largest tax credits offered by the government. The credit has since been made permanent to incentivize companies to hire technical talent and continue innovating.
The R&D Tax Credit not only applies to formulation and testing done in labs but also extends to include daily activities in drug production.
WATCH DEAN ZERBE EXPLAIN WHY R&D TAX CREDIT IS THE BEST SOURCE OF REFUNDS FOR BUSINESSES
WHITEPAPER
R&D Tax Credit: Driving Innovation and Job Creation
R&D | Generic Whitepaper
Please complete the form below to download the whitepaper and maximize your return in 2021
Hear from our clients
The return on our investment in the alliantgroup study was substantial. I’m happy to recommend alliantgroup because they did a great job serving my company as a consultant. Their team of tax experts will be an excellent resource for any other company.
NUTRACEUTICAL MANUFACTURER
The methodology that alliantgroup has developed clearly allowed us to benefit from the maximum limit of the R&D Tax Credit. Many of our everyday activities, including our contract manufacturing, qualified in a big way for this vital tax incentive.
CONTRACT PHARMACEUTICAL MANUFACTURER
Maximize your R&D Tax Credits: Check if you qualify!
We’ll help determine your eligibility, document your processes, and maximize your return! Complete the form below to estimate the credits your company may be entitled to.
By clicking Submit, I agree to the use of my personal data in accordance with alliantgroup Privacy Policy. alliantgroup will not sell, trade, lease, or rent your personal data to third parties.
Ready to get started?
Schedule a free consultation with our team of experts to learn more.
We’ll discuss your eligibility and help estimate your potential tax benefit.